Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocugen (OCGN) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Ocugen (OCGN) over the last 7 years, with Q3 2025 value amounting to 1141.84%.

  • Ocugen's EBITDA Margin rose 3300.0% to 1141.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 1191.53%, marking a year-over-year decrease of 1032700.0%. This contributed to the annual value of 1332.33% for FY2024, which is 2872000.0% down from last year.
  • According to the latest figures from Q3 2025, Ocugen's EBITDA Margin is 1141.84%, which was up 3300.0% from 1075.53% recorded in Q2 2025.
  • Over the past 5 years, Ocugen's EBITDA Margin peaked at 35385.0% during Q1 2021, and registered a low of 5127.25% during Q3 2022.
  • Over the past 5 years, Ocugen's median EBITDA Margin value was 1257.18% (recorded in 2024), while the average stood at 129.98%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 90916700bps in 2021, then tumbled by -391880000bps in 2022.
  • Ocugen's EBITDA Margin (Quarter) stood at 35385.0% in 2021, then plummeted by -107bps to 2548.12% in 2022, then soared by 69bps to 779.06% in 2023, then tumbled by -133bps to 1813.48% in 2024, then surged by 37bps to 1141.84% in 2025.
  • Its EBITDA Margin stands at 1141.84% for Q3 2025, versus 1075.53% for Q2 2025 and 1037.0% for Q1 2025.